MAGELLAN LONGEVITY
HomeResearchStudy library › Does curcumin supplementation effectively reduce systemic…
Study summary · Immunity, inflammation & resilience

Does curcumin supplementation effectively reduce systemic inflammatory mediators in humans?

In one paragraph

High-Bioavailability Curcumin, a systematic review and meta-analysis (Nutr Rev 2021, PMID 34378053) — pooled data from 28 meta-analyzed trials (N = 2,038 participants) showed that curcumin supplementation significantly reduced C-reactive protein (-1.55 mg/L), interleukin-6 (-1.69 pg/mL), tumor necrosis factor " (-3.13 pg/mL), IL-8 (-0.54 pg/mL), and monocyte chemoattractant protein-1 (-2.48 pg/mL). Reported result: but had no effect on intracellular adhesion molecule-1.

Source: Nutr Rev 2021, PMID 34378053 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Nutr Rev · 2021 · PMID 34378053 · DOI 10.1093/nutrit/nuaa114

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Curcumin supplementation can reduce several markers of inflammation in humans, but more research is needed to determine optimal usage.

The question

Does curcumin supplementation effectively reduce systemic inflammatory mediators in humans?

What they tested

The study implicitly hypothesizes that curcumin, a known anti-inflammatory agent in preclinical research, will demonstrate efficacy in reducing systemic inflammatory mediators in humans.

How they did it

This systematic review and meta-analysis searched Medline, CINAHL, EMBASE, Scopus, and Cochrane databases for randomized controlled trials from 1980 to May 2019. Eligible studies investigated dietary curcumin's effects on inflammatory mediators in humans not receiving anti-inflammatory treatment. Two authors independently screened articles, and evidence quality was appraised using the Quality Criteria Checklist for Primary Research. Thirty-two trials were included, and 28 were meta-analyzed using a random-effects model.

What they found

Pooled data from 28 meta-analyzed trials (N = 2,038 participants) showed that curcumin supplementation significantly reduced C-reactive protein (-1.55 mg/L), interleukin-6 (-1.69 pg/mL), tumor necrosis factor " (-3.13 pg/mL), IL-8 (-0.54 pg/mL), and monocyte chemoattractant protein-1 (-2.48 pg/mL). It also increased IL-10 (0.49 pg/mL), but had no effect on intracellular adhesion molecule-1.

Effect of Curcumin on Inflammatory Mediators
Values shown: Weighted Mean Difference
C-reactive protein-1.55
Interleukin-6-1.69
Tumor necrosis factor ",-3.13
IL-8-0.54
Monocyte chemoattractant protein-1-2.48
IL-100.49

Weighted mean difference in inflammatory mediators after curcumin supplementation.

What it means

Curcumin supplementation demonstrates anti-inflammatory effects by reducing several systemic inflammatory mediators and increasing IL-10. Further research is needed to optimize dose, duration, and formulation for chronic inflammation in humans.

Limitations

The abstract does not explicitly state limitations of the review, but it does highlight that clinical evidence for curcumin remains inconclusive due to discrepancies regarding optimal dosage, duration, and formulation, suggesting these are areas needing further clarification.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“a reduction in C-reactive protein, interleukin-6 and tumor necrosis factor”— from the published abstract, Nutr Rev 2021

The paper at a glance

Magellan’s evidence labellowers CRP, IL-6, TNF-alpha (our label for this citation — see PubMed for the paper’s own title and authors)
JournalNutr Rev
Year2021
PMID34378053 ↗
DOI10.1093/nutrit/nuaa114 ↗
TopicImmunity, inflammation & resilience

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

High-Bioavailability Curcumin

Meta-analyses of randomized controlled trials generally find that curcumin/turmeric supplementation lowers CRP, IL-6 and TNF-alpha and improves oxidative-stress markers, with symptomatic benefits reported in osteoarthritis and rheumatoid arthritis, modest LDL-cholesterol and triglyceride reductions in cardiometabolic…

High-Bioavailability Curcumin

Curcumin is the principal curcuminoid and yellow pigment of turmeric (Curcuma longa), a rhizome long…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does curcumin supplementation effectively reduce systemic inflammatory mediators in humans? [Plain-English summary of Nutr Rev 2021, PMID 34378053, DOI 10.1093/nutrit/nuaa114]. Magellan Longevity. https://magellanlongevity.com/study/s104.html
BibTeX
@misc{magellan_s104, title = {Does curcumin supplementation effectively reduce systemic inflammatory mediators in humans?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s104.html}}, note = {Plain-English summary of PubMed PMID 34378053; DOI 10.1093/nutrit/nuaa114; Nutr Rev 2021. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s104.html

Related studies in the Magellan library

All 17 Magellan summaries on immunity, inflammation & resilience →

How this summary was made. Every section above restates what the published abstract of PMID 34378053 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.